Article
Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals.
The Journal of antimicrobial chemotherapy - 1 Nov 2020
Chimukangara Benjamin, Giandhari Jennifer, Lessells Richard, Yende-Zuma Nonhlanhla, Sartorius Benn, Samuel Reshmi, Khanyile Khulekani S, Stray-Pedersen Babill, Moodley Pravi, Metzner Karin J, Padayatchi Nesri, Naidoo Kogieleum, De Oliveira Tulio
Abstract excerpt
OBJECTIVES: To determine the impact of pretreatment low-abundance HIV-1 drug-resistant variants (LA-DRVs) on virological failure (VF) among HIV-1/TB-co-infected individuals treated with NNRTI first-line ART. METHODS: We conducted a case-control study of 170 adults with HIV-1/TB co-infection. Cases had at least one viral load (VL) ≥1000 RNA copies/mL after ≥6 months on NNRTI-based ART, and controls had sustained...
Topics
- Adult
- Anti-HIV Agents
- Case-Control Studies
- Coinfection
- Drug Resistance, Viral
- HIV Infections
- HIV-1
- Humans
- Mutation
- Pharmaceutical Preparations
